Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
3,200,366
-
Share change
-
+148,758
-
Total reported value
-
$332,157,004
-
Price per share
-
$103.80
-
Number of holders
-
69
-
Value change
-
+$17,730,526
-
Number of buys
-
33
-
Number of sells
-
32
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2014
As of 30 Jun 2014,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,200,366 shares.
The largest 10 holders included
MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, FMR LLC, UBS AG, MATHER GROUP, INC., Wharton Business Group, LLC, NIEMANN CAPITAL MANAGEMENT INC, LPL Financial LLC, and WELLS FARGO & COMPANY/MN.
This page lists
69
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.